Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs Cora Health

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Cora Health a 83. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

Cora Health

#45 · Grade B+ · Good Value

Est. first month

From $99/mo (all doses, 12-month plan, compounded)

Save ~93% vs brand-name
Get this deal Full Cora Health review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 83 an est. $99/mo first month, with no teaser step-up baked in. Cora Health isn't out of it: Shoppers who want flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsCora Health
Value Score90 (A)83 (B+)
Est. first month$99/moFrom $99/mo (all doses, 12-month plan, compounded)
Save vs brand-name~93%~93%
Semaglutide$99/moFrom $99/mo (all doses, 12-month plan, compounded)
Tirzepatide$145/moFrom $135/mo (all doses, 12-month plan, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
90
Alan Meds: 95. Cora Health: 90.
85
No Teaser-Rate Bait
80
Alan Meds: 85. Cora Health: 80.
98
Nationwide Availability
96
Alan Meds: 98. Cora Health: 96.
94
Both Molecules
92
Alan Meds: 94. Cora Health: 92.
82
Easy Cancellation
58
Alan Meds: 82. Cora Health: 58.
72
Reputation
68
Alan Meds: 72. Cora Health: 68.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

Cora Health

Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.

Why it's a deal

  • Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
  • Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
  • LegitScript Certified (seal ID 49690100 in footer)
  • Flat per-tier pricing — no dose-escalation surcharge
  • Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide

The fine print

  • Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
  • Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
  • Lowest advertised prices require 12-month commitment with no partial refunds
  • No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
  • Founder names and funding undisclosed on site
Get the Alan Meds deal Get the Cora Health deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Cora Health.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.